Report Detail
Global Overactive Bladder Treatment Market Growth 2019-2024
- RnM2906528 |
- 08 February, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Other
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
According to this study, over the next five years the Overactive Bladder Treatment market will register a 5.4% CAGR in terms of revenue, the global market size will reach US$ 6460 million by 2024, from US$ 4710 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Overactive Bladder Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Overactive Bladder Treatment market by product type, application, key manufacturers and key regions and countries.
This study considers the Overactive Bladder Treatment value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anticholinergics
Mirabegron
Botox
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Overactive Bladder Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Overactive Bladder Treatment market by identifying its various subsegments.
Focuses on the key global Overactive Bladder Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Overactive Bladder Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Overactive Bladder Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Overactive Bladder Treatment Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Overactive Bladder Treatment Consumption 2014-2024
- 2.1.2 Overactive Bladder Treatment Consumption CAGR by Region
- 2.2 Overactive Bladder Treatment Segment by Type
- 2.2.1 Anticholinergics
- 2.2.2 Mirabegron
- 2.2.3 Botox
- 2.3 Overactive Bladder Treatment Consumption by Type
- 2.3.1 Global Overactive Bladder Treatment Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Overactive Bladder Treatment Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Overactive Bladder Treatment Sale Price by Type (2014-2019)
- 2.4 Overactive Bladder Treatment Segment by Application
- 2.4.1 Idiopathic Overactive Bladder
- 2.4.2 Neurogenic Overactive Bladder
- 2.5 Overactive Bladder Treatment Consumption by Application
- 2.5.1 Global Overactive Bladder Treatment Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Overactive Bladder Treatment Value and Market Share by Application (2014-2019)
- 2.5.3 Global Overactive Bladder Treatment Sale Price by Application (2014-2019)
3 Global Overactive Bladder Treatment by Players
- 3.1 Global Overactive Bladder Treatment Sales Market Share by Players
- 3.1.1 Global Overactive Bladder Treatment Sales by Players (2017-2019)
- 3.1.2 Global Overactive Bladder Treatment Sales Market Share by Players (2017-2019)
- 3.2 Global Overactive Bladder Treatment Revenue Market Share by Players
- 3.2.1 Global Overactive Bladder Treatment Revenue by Players (2017-2019)
- 3.2.2 Global Overactive Bladder Treatment Revenue Market Share by Players (2017-2019)
- 3.3 Global Overactive Bladder Treatment Sale Price by Players
- 3.4 Global Overactive Bladder Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Overactive Bladder Treatment Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Overactive Bladder Treatment Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Overactive Bladder Treatment by Regions
- 4.1 Overactive Bladder Treatment by Regions
- 4.1.1 Global Overactive Bladder Treatment Consumption by Regions
- 4.1.2 Global Overactive Bladder Treatment Value by Regions
- 4.2 Americas Overactive Bladder Treatment Consumption Growth
- 4.3 APAC Overactive Bladder Treatment Consumption Growth
- 4.4 Europe Overactive Bladder Treatment Consumption Growth
- 4.5 Middle East & Africa Overactive Bladder Treatment Consumption Growth
5 Americas
- 5.1 Americas Overactive Bladder Treatment Consumption by Countries
- 5.1.1 Americas Overactive Bladder Treatment Consumption by Countries (2014-2019)
- 5.1.2 Americas Overactive Bladder Treatment Value by Countries (2014-2019)
- 5.2 Americas Overactive Bladder Treatment Consumption by Type
- 5.3 Americas Overactive Bladder Treatment Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Overactive Bladder Treatment Consumption by Countries
- 6.1.1 APAC Overactive Bladder Treatment Consumption by Countries (2014-2019)
- 6.1.2 APAC Overactive Bladder Treatment Value by Countries (2014-2019)
- 6.2 APAC Overactive Bladder Treatment Consumption by Type
- 6.3 APAC Overactive Bladder Treatment Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Overactive Bladder Treatment by Countries
- 7.1.1 Europe Overactive Bladder Treatment Consumption by Countries (2014-2019)
- 7.1.2 Europe Overactive Bladder Treatment Value by Countries (2014-2019)
- 7.2 Europe Overactive Bladder Treatment Consumption by Type
- 7.3 Europe Overactive Bladder Treatment Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Overactive Bladder Treatment by Countries
- 8.1.1 Middle East & Africa Overactive Bladder Treatment Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Overactive Bladder Treatment Value by Countries (2014-2019)
- 8.2 Middle East & Africa Overactive Bladder Treatment Consumption by Type
- 8.3 Middle East & Africa Overactive Bladder Treatment Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Overactive Bladder Treatment Distributors
- 10.3 Overactive Bladder Treatment Customer
11 Global Overactive Bladder Treatment Market Forecast
- 11.1 Global Overactive Bladder Treatment Consumption Forecast (2019-2024)
- 11.2 Global Overactive Bladder Treatment Forecast by Regions
- 11.2.1 Global Overactive Bladder Treatment Forecast by Regions (2019-2024)
- 11.2.2 Global Overactive Bladder Treatment Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Overactive Bladder Treatment Forecast by Type
- 11.8 Global Overactive Bladder Treatment Forecast by Application
12 Key Players Analysis
- 12.1 Astellas Pharma
- 12.1.1 Company Details
- 12.1.2 Overactive Bladder Treatment Product Offered
- 12.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Astellas Pharma News
- 12.2 Allergan
- 12.2.1 Company Details
- 12.2.2 Overactive Bladder Treatment Product Offered
- 12.2.3 Allergan Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Allergan News
- 12.3 Pfizer
- 12.3.1 Company Details
- 12.3.2 Overactive Bladder Treatment Product Offered
- 12.3.3 Pfizer Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Pfizer News
- 12.4 Teva (Activas)
- 12.4.1 Company Details
- 12.4.2 Overactive Bladder Treatment Product Offered
- 12.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Teva (Activas) News
- 12.5 Johnson & Johnson
- 12.5.1 Company Details
- 12.5.2 Overactive Bladder Treatment Product Offered
- 12.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Johnson & Johnson News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Overactive Bladder Treatment . Industry analysis & Market Report on Overactive Bladder Treatment is a syndicated market report, published as Global Overactive Bladder Treatment Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Overactive Bladder Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
